|
1
|
Shah T and Venur VA: Central nervous
system lymphoma. Semin Neurol. 43:825–832. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hernández-Verdin I, Morales-Martínez A,
Hoang-Xuan K and Alentorn A: Primary central nervous system
lymphoma: Advances in its pathogenesis, molecular markers and
targeted therapies. Curr Opin Neurol. 35:779–786. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoang-Xuan K, Deckert M, Ferreri AJM,
Furtner J, Gallego Perez-Larraya J, Henriksson R, Hottinger AF,
Kasenda B, Lefranc F, Lossos A, et al: European association of
neuro-oncology (EANO) guidelines for treatment of primary central
nervous system lymphoma (PCNSL). Neuro Oncol. 25:37–53. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liao B, Kamiya-Matsuoka C, Gong Y, Chen M,
Wolf BA and Fowler NH: Primary natural killer/T-cell lymphoma
presenting as leptomeningeal disease. J Neurol Sci. 343:46–50.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Huang M, Zhang Z, Jing H, Zou Y
and Bu H: Primary meningeal central nervous system lymphoma: A case
report and literature review. Medicine (Baltimore). 101:e325672022.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pietras NM, Gupta N, Justiz Vaillant AA
and Pearson-Shaver AL: Immune thrombocytopenia. StatPearls
[Internet] Treasure Island (FL): StatPearls Publishing; 2024
|
|
7
|
Guo Y, Liu X, Zihao Z, Zhang Q, Shi Z and
Zhang N: Blood routine reference value range should be adjusted
according to regional and ethnic characteristics. Front Public
Health. 10:9341012022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sabattini E, Bacci F, Sagramoso C and
Pileri SA: WHO classification of tumours of haematopoietic and
lymphoid tissues in 2008: An overview. Pathologica. 102:83–87.
2010.PubMed/NCBI
|
|
9
|
Guan H, Huang Y, Wen W, Xu M, Zan Q and
Zhang Z: Primary central nervous system extranodal NK/T-cell
lymphoma, nasal type: Case report and review of the literature. J
Neurooncol. 103:387–391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Yu H, Fu X, Zhang L, Li X, Li L,
Wang X, Sun Z, Zhang X, Li Z, et al: Clinical analysis of patients
with primary and secondary extranodal natural killer/T-cell
lymphoma of central nervous system. Hematol Oncol. 41:267–274.
2023. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Küker W, Nägele T, Korfel A, Heckl S,
Thiel E, Bamberg M, Weller M and Herrlinger U: Primary central
nervous system lymphomas (PCNSL): MRI features at presentation in
100 patients. J Neurooncol. 72:169–177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Capasso R, Negro A, Russo C, Zeccolini F,
Muto G, Caranci F and Prof Pinto A: Conventional and advanced MRI
Techniques in the evaluation of primary CNS lymphoma. Semin
Ultrasound CT MR. 44:126–135. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zing NF, Thais F, Massimo C, Chiattone C
and Ferreri AJM: Diagnosis, prevention and treatment of central
nervous system involvement in peripheral t-cell lymphomas. Crit Rev
Oncol Hematol. 167:1034962021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kleinschmidt-DeMasters BK and Gilani A:
Secondary parenchymal CNS involvement by lymphoma including rare
types: Follicular and EBV-positive NK/T cell lymphoma, nasal type.
Ann Diagn Pathol. 53:1517652021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kajtazi NI, Bafaquh M, Ghamdi JA, AlEissa
Z, Shmeikh AA, Alsaeed A, Sulaiman T, Vizcaino MA, Al Hameed M and
Raghunathan A: An unusual case of EBV-negative primary CNS lymphoma
of natural killer/T-cell lineage. Clin Pathol.
14:2632010X2110656922021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ball MK, Morris JM, Wood AJ, Meyer FB,
Kaszuba MC and Raghunathan A: Ventricle-predominant primary CNS
lymphomas: Clinical, radiological and pathological evaluation of
five cases and review of the literature. Brain Tumor Pathol.
37:22–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kan Y, Wang Y, Wang W, Liu J and Yang J:
Unexpected corpus callosum involvement of diffuse large B-cell
lymphoma on FDG PET/CT. Clin Nucl Med. 43:933–935. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guedes BF and Cury RG: Trigeminal nerve
thickening in chronic inflammatory demyelinating polyneuropathy.
Arq Neuropsiquiatr. 73:634–635. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nikanjam M, Kato S and Kurzrock R: Liquid
biopsy: Current technology and clinical applications. J Hematol
Oncol. 15:1312022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Liang L, Li D, Nong L, Zheng Y,
Huang S, Zhang B and Li T: JAK3/STAT3 oncogenic pathway and PRDM1
expression stratify clinicopathologic features of extranodal
NK/T-cell lymphoma, nasal type. Oncol Rep. 41:3219–3232.
2019.PubMed/NCBI
|
|
21
|
Koo GC, Tan SY, Tang T, Poon SL, Allen GE,
Tan L, Chong SC, Ong WS, Tay K, Tao M, et al: Janus kinase
3-activating mutations identified in natural killer/T-cell
lymphoma. Cancer Discov. 2:591–597. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamaguchi J, Ohka F, Kitano Y, Maeda S,
Motomura K, Aoki K, Takeuchi K, Nagata Y, Hattori H, Tsujiuchi T,
et al: Rapid detection of the MYD88 L265P mutation for pre- and
intra-operative diagnosis of primary central nervous system
lymphoma. Cancer Sci. 114:2544–2551. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iriyama C, Murate K, Iba S, Okamoto A,
Goto N, Yamamoto H, Kato T, Mihara K, Miyama T, Hattori K, et al:
Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS
lymphoma from cerebrospinal infectious/demyelinating diseases.
Cancer Med. 12:16972–16984. 2023. View Article : Google Scholar : PubMed/NCBI
|
